The price-to-earnings ratio for Chemours Company (NYSE: CC) is above average at 25.26x. The 36-month beta value for CC is also noteworthy at 1.80. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for CC is 148.42M, and at present, short sellers hold a 5.93% of that float. The average trading volume of CC on March 19, 2025 was 2.07M shares.
CC) stock’s latest price update
Chemours Company (NYSE: CC) has experienced a rise in its stock price by 0.21 compared to its previous closing price of 14.60. However, the company has seen a gain of 7.10% in its stock price over the last five trading days. prnewswire.com reported 2025-03-18 that DENVER, March 18, 2025 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) and The Chemours Company (NYSE: CC) today announced they are forming a strategic alliance to expand the companies’ existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations.
CC’s Market Performance
Chemours Company (CC) has seen a 7.10% rise in stock performance for the week, with a -13.07% decline in the past month and a -24.59% plunge in the past quarter. The volatility ratio for the week is 4.59%, and the volatility levels for the past 30 days are at 5.39% for CC. The simple moving average for the past 20 days is -1.61% for CC’s stock, with a -25.42% simple moving average for the past 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with Truist repeating the rating for CC by listing it as a “Buy.” The predicted price for CC in the upcoming period, according to Truist is $27 based on the research report published on January 28, 2025 of the current year 2025.
UBS, on the other hand, stated in their research note that they expect to see CC reach a price target of $30, previously predicting the price at $28. The rating they have provided for CC stocks is “Buy” according to the report published on July 09th, 2024.
Mizuho gave a rating of “Neutral” to CC, setting the target price at $25 in the report published on June 07th of the previous year.
CC Trading at -14.17% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.91% of loss for the given period.
Volatility was left at 5.39%, however, over the last 30 days, the volatility rate increased by 4.59%, as shares sank -16.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.45% lower at present.
During the last 5 trading sessions, CC rose by +7.10%, which changed the moving average for the period of 200-days by -42.51% in comparison to the 20-day moving average, which settled at $14.87. In addition, Chemours Company saw -13.43% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from Scarborough Alvenia, who sale 7,500 shares at the price of $20.64 back on Nov 07 ’24. After this action, Scarborough Alvenia now owns 16,645 shares of Chemours Company, valued at $154,771 using the latest closing price.
Scarborough Alvenia, the Officer of Chemours Company, proposed sale 7,500 shares at $20.00 during a trade that took place back on Nov 06 ’24, which means that Scarborough Alvenia is holding shares at $150,000 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.2 for the gross margin
The net margin for Chemours Company stands at 0.02. The total capital return value is set at 0.07. Equity return is now at value 12.98, with 1.10 for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.15. The debt to equity ratio resting at 7.21. The interest coverage ratio of the stock is 1.43.
Currently, EBITDA for the company is 692.0 million with net debt to EBITDA at 5.41. When we switch over and look at the enterprise to sales, we see a ratio of 1.01. The receivables turnover for the company is 7.51for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.68.
Conclusion
In summary, Chemours Company (CC) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
